- Home
- Cohen Arthur Bruce
Insider Trading History of Cohen Arthur Bruce
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cohen Arthur Bruce since 2007.
The trader's CIK number is 1343780.
At the time of the last reporting, Cohen Arthur Bruce was the 10% Owner of Valeant Pharmaceuticals International. (stock ticker symbol VRX).
Also see all insider trading activities at Valeant Pharmaceuticals International.
Note that in the past
Cohen Arthur Bruce also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Valeant Pharmaceuticals International (VRX) by Cohen Arthur Bruce
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | VRX | 1,000,000 | $15,760,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Chelsea Therapeutics International, Ltd. (CHTB.OB) by Cohen Arthur Bruce
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | CHTB.OB | 325,979 | $1,554,300 | 8,000 | $56,000 | 0 | $0 |
Yearly summary of insider trading at Trimeris Inc (TRMS) by Cohen Arthur Bruce
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | TRMS | 794,905 | $5,743,367 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Minrad International, Inc. (BUF) by Cohen Arthur Bruce
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | BUF | 873,000 | $4,114,347 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Cohen Arthur Bruce:
1. Valeant Pharmaceuticals International (VRX)
2. Chelsea Therapeutics International, Ltd. (CHTB.OB)
3. Trimeris Inc (TRMS)
4. Minrad International, Inc. (BUF)
Table 1. Insider trading of Valeant Pharmaceuticals International (VRX) by Cohen Arthur Bruce
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-10-29 | VRX | Buy | 1,000,000 | 15.76 | 15,760,000 |
Table 2. Insider trading of Chelsea Therapeutics International, Ltd. (CHTB.OB) by Cohen Arthur Bruce
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-06-29 | CHTB.OB | Sale | 8,000 | 7.00 | 56,000 |
2007-06-29 | CHTB.OB | Buy | 8,000 | 6.68 | 53,440 |
2007-03-22 | CHTB.OB | Buy | 317,979 | 4.72 | 1,500,860 |
Table 3. Insider trading of Trimeris Inc (TRMS) by Cohen Arthur Bruce
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-10-01 | TRMS | Buy | 54,410 | 7.78 | 423,255 |
2007-09-27 | TRMS | Buy | 33,746 | 7.39 | 249,517 |
2007-09-28 | TRMS | Buy | 145,590 | 7.64 | 1,112,453 |
2007-09-21 | TRMS | Buy | 300,000 | 7.11 | 2,133,600 |
2007-08-17 | TRMS | Buy | 9,600 | 7.01 | 67,324 |
2007-08-20 | TRMS | Buy | 1,300 | 7.01 | 9,110 |
2007-08-21 | TRMS | Buy | 54,525 | 7.07 | 385,655 |
2007-08-22 | TRMS | Buy | 10,829 | 7.11 | 76,994 |
2007-08-13 | TRMS | Buy | 184,905 | 6.95 | 1,285,459 |
Table 4. Insider trading of Minrad International, Inc. (BUF) by Cohen Arthur Bruce
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-09-07 | BUF | Buy | 5,900 | 4.54 | 26,786 |
2007-09-10 | BUF | Buy | 33,600 | 4.53 | 152,208 |
2007-09-11 | BUF | Buy | 5,000 | 4.55 | 22,750 |
2007-09-12 | BUF | Buy | 12,500 | 4.50 | 56,250 |
2007-08-23 | BUF | Buy | 40,900 | 4.70 | 192,230 |
2007-08-14 | BUF | Buy | 55,900 | 4.84 | 270,556 |
2007-08-13 | BUF | Buy | 3,200 | 4.90 | 15,680 |
2007-09-04 | BUF | Buy | 46,700 | 4.84 | 226,028 |
2007-08-03 | BUF | Buy | 616,000 | 4.71 | 2,898,280 |
2007-08-31 | BUF | Buy | 40,000 | 4.80 | 192,000 |
2007-08-30 | BUF | Buy | 13,300 | 4.63 | 61,579 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cohen Arthur Bruce
(10% Owner of Valeant Pharmaceuticals International at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.